Viewing Opinion | StockChase
Abbott Labs (ABT-N) opinion on 2012-07-09

Last Price Recorded: 55.5600 on 2017-11-17

ON STOCKCHASE SINCE Jan 2001

biotechnology/pharmaceutical
COMMENT

Christine Poole
Abbott Labs was $65.610 at time of opinion
Owned : Yes

Will be splitting the company into 2 parts, pharma side and medical devices. Purchased a generic company out of India last year and India will be providing health care to the general population but will only pay for generic drugs . Currently within a couple of dollars of her target price so she might shave some of her holdings.
CAUTIOUS

All opinions for ABT-N (106)

30 BUY
5 BUY on WEAKNESS
17 COMMENT
7 DON'T BUY
6 HOLD
14 PAST TOP PICK
1 SELL
1 SELL ON STRENGTH
23 TOP PICK
2 WAIT
View All

More experts covering ABT-N

SAVE
Add ABT-N to Watch List

All opinions for ABT-N (106)

30 BUY
5 BUY on WEAKNESS
17 COMMENT
7 DON'T BUY
6 HOLD
14 PAST TOP PICK
1 SELL
1 SELL ON STRENGTH
23 TOP PICK
2 WAIT
View All

More experts covering ABT-N

SAVE
Add ABT-N to Watch List

No Comments.


You must be logged in to comment.

Successfully Saved Company